Ke, X. and Ma, T. (2025) Protective Effect of Liraglutide on Early Renal Fibrosis in Diabetes Mice. Journal of Biosciences and Medicines, 13, 84-91. doi: 10.4236/jbm.2025.131008 .
Irish Independent on MSN1d
Patients taking weight-loss jabs at clinic had ‘significant reduction’ in alcohol intake, study showsHeavy drinkers who were taking weight-loss jabs in a Dublin clinic significantly reduced their alcohol intake down from 12 to four pints a week, according to a new study. The research was carried ...
A recent breakthrough in medical research offers exciting possibilities for people dealing with diabetes and obesity. This ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback